Weight and Metabolic Outcomes 12 Years after Gastric Bypass

Obesity and Bariatric Surgery

Purse-string transoral outlet reduction (TORe) is effective at inducing weight loss and improvement in metabolic comorbidities after Roux-en-Y gastric bypass

Endoscopy.

Jirapinyo P, Kröner PT, Thompson CC

doi: 10.1055/s-0043-122380.

COMMENTED

Obesity and Bariatric Surgery

Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults

N Engl J Med.

Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Brandt ML, Xanthakos SA, Dixon JB, Harmon CM, Chen MK, Xie C, Evans ME, Helmrath MA, Teen–LABS Consortium.

doi: 10.1056/NEJMoa1813909.

Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery

Clinical and Patient-Centered Outcomes in Obese Type 2 Diabetes Patients 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study

Diabetes Care.

Simonson DC, Halperin F, Foster K, Vernon A, Goldfine AB

doi: 10.2337/dc17-0487.

COMMENTED

Diabetes - GeneralLipidsObesity and Bariatric Surgery

Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study

JAMA Surg.

Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, Gourash W, Horlick M, Mitchell JE, Pomp A, Pories WJ, Purnell JQ, Singh A, Spaniolas K, Thirlby R, Wolfe BM, Yanovski SZ

doi: 10.1001/

Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery

Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect.

Diabetes Care.

Holter MM, Dutia R, Stano SM, Prigeon RL2, Homel P, McGinty JJ Jr, Belsley SJ, Ren CJ, Rosen D, Laferrère B

doi: 10.2337/dc16-1376.

Obesity and Bariatric Surgery

An Extended Pouch in a Roux-En-Y Gastric Bypass Reduces Weight Regain: 3-Year Results of a Randomized Controlled Trial

Obes Surg.

Boerboom A, Cooiman M, Aarts E, Aufenacker T, Hazebroek E, Berends F

doi: 10.1007/s11695-019-04156-0.

Obesity and Bariatric Surgery

Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding

ISME J.

Ilhan ZE, DiBaise JK, Isern NG, Hoyt DW, Marcus AK, Kang DW, Crowell MD, Rittmann BE, Krajmalnik-Brown R

doi: 10.1038/ismej.2017.71.

COMMENTED

Obesity and Bariatric Surgery

Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial

Lancet.

Robert M, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L, Poghosyan T, Chevallier JM, Malherbe V, Chouillard E, Reche F, Torcivia A, Maucort-Boulch D, Bin-Dorel S, Langlois-Jacques C, Delaunay D, Pattou F, Disse E

doi: 10.1016/S0140-6736(19)30475-1.

Type 2 DiabetesObesity and Bariatric Surgery

Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB)

Metabolism.

Shah M, Laurenti MC, Man CD, Ma J, Cobelli C, Rizza RA, Vella A

doi: 10.1016/j.metabol.2018.12.005.

Related content

Purse-string transoral outlet reduction (TORe) is effective at inducing weight loss and improvement in metabolic comorbidities after Roux-en-Y gastric bypass

Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults

Clinical and Patient-Centered Outcomes in Obese Type 2 Diabetes Patients 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study

Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study

Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect.

An Extended Pouch in a Roux-En-Y Gastric Bypass Reduces Weight Regain: 3-Year Results of a Randomized Controlled Trial

Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding

Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial

Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB)